Lack of benefit of 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer with microsatellite instability

Clinical Colorectal Cancer

Volumn 2, Issue 3, 2002, Pages 146-148

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; TUMOR MARKER;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER GENETICS; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE ASSOCIATION; DRUG EFFICACY; GENE MUTATION; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PHENOTYPE; REGULATOR GENE;

EID: 0036864503     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1533-0028(11)70320-6     Document Type: Article

References (11)

1. Starostik P, Muller-Hermelink HK. Diagnosis of microsatellite instability-positive colorectal cancer. Expert Rev Mol Diagn 2001; 1:71-80.
2. Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342:69-77.
3. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58:5248-5257.
4. Haydon AM, Jass JR. Emerging pathways in colorectal-cancer development. Lancet Oncol 2002; 3:83-88.
5. Carethers JM, Hawn MT, Chauhan DP, et al. Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methl-N'-nitro-N-nitrosoguanidine. J Clin Invest 1996; 14:255-257.
6. Souza RF, Appel R, Yin J, et al. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 1998; 58:5473-5477.
7. Karnes WE, Jr., Shattuck-Brandt R, Burgart LJ, et al. Reduced COX-2 protein in colorectal cancer with defective mismatch repair. Cancer Res 1998; 58:5473-5477.
8. Elsaleh H, Joseph D, Grieu F, et al. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 2000; 355:1745-1750.
9. Hemminki A, Mecklin JP, Jarvinen H, et al. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 2000; 119:921-928.
10. Watanabe T, Wu TT, Catalano PJ, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001; 344:1196-1206.
11. Ribic C, Sargent D, Moore MJ. Tumor microsatellite instability (MSI) and the benefit of 5-FU based chemotherapy in stage II & III colon cancer: a pooled molecular reanalysis of randomized chemotherapy trials. Proc Am Soc Clin Oncol 2002; 21:128a (Abstract #509).